Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson's disease.
J Neuroinflammation
; 16(1): 50, 2019 Feb 27.
Article
en En
| MEDLINE
| ID: mdl-30813952
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Enfermedad de Parkinson
/
Levodopa
/
Estrés Oxidativo
/
Inflamación
/
Antiparkinsonianos
Límite:
Aged
/
Female
/
Humans
/
Male
Idioma:
En
Año:
2019
Tipo del documento:
Article